Hepatocyte growth factor reduces sensitivity to the epidermal growth factor receptor-tyrosine kinase inhibitor, gefitinib, in lung adenocarcinoma cells harboring wild-type <i>EGFR</i>

Hua Yang, Wei Wang|Oncotarget|2016

Cited by 12